212 related articles for article (PubMed ID: 36543601)
1. Gender identity: Current concepts and gender-affirming hormone therapy.
Pérez López G
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():27-37. PubMed ID: 36543601
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice guidelines for transsexual, transgender and gender diverse minors.
Moral-Martos A; Guerrero-Fernández J; Gómez-Balaguer M; Rica Echevarría I; Campos-Martorell A; Chueca-Guindulain MJ; García García E; Hoyos-Gurrea R; López de Lara D; López-Siguero JP; Martos Tello JM; Mora Palma C; Riaño Galán I; Yeste Fernández D
An Pediatr (Engl Ed); 2022 Apr; 96(4):349.e1-349.e11. PubMed ID: 35534418
[TBL] [Abstract][Full Text] [Related]
3. European Society for Sexual Medicine Position Statement "Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction".
T'Sjoen G; Arcelus J; De Vries ALC; Fisher AD; Nieder TO; Özer M; Motmans J
J Sex Med; 2020 Apr; 17(4):570-584. PubMed ID: 32111534
[TBL] [Abstract][Full Text] [Related]
4. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
Rowniak S; Bolt L; Sharifi C
JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
[TBL] [Abstract][Full Text] [Related]
5. Executive summary: Quality standards of care units for people with sexual and gender diversity.
Gómez Hoyos E; Cabrera García P; Gómez Balaguer M;
Endocrinol Diabetes Nutr (Engl Ed); 2024 Apr; 71(4):181-186. PubMed ID: 38714477
[TBL] [Abstract][Full Text] [Related]
6. SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people.
Fisher AD; Senofonte G; Cocchetti C; Guercio G; Lingiardi V; Meriggiola MC; Mosconi M; Motta G; Ristori J; Speranza AM; Pierdominici M; Maggi M; Corona G; Lombardo F
J Endocrinol Invest; 2022 Mar; 45(3):657-673. PubMed ID: 34677807
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review.
Defreyne J; Motmans J; T'sjoen G
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):543-556. PubMed ID: 28972413
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
9. Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation.
Hayon R; Stevenson K
Facial Plast Surg Clin North Am; 2019 May; 27(2):179-190. PubMed ID: 30940383
[TBL] [Abstract][Full Text] [Related]
10. Gender-affirming hormone therapy: An updated literature review with an eye on the future.
D'hoore L; T'Sjoen G
J Intern Med; 2022 May; 291(5):574-592. PubMed ID: 34982475
[TBL] [Abstract][Full Text] [Related]
11. Transmasculine Hormone Therapy.
Defreyne J; T'Sjoen G
Endocrinol Metab Clin North Am; 2019 Jun; 48(2):357-375. PubMed ID: 31027545
[TBL] [Abstract][Full Text] [Related]
12. [Medical management of transgender children and adolescents].
Castilla-Peón MF
Bol Med Hosp Infant Mex; 2018; 75(1):7-14. PubMed ID: 29652872
[TBL] [Abstract][Full Text] [Related]
13. Difficulties of gender affirming treatment in trans women with BRCA1+ mutation: A case report.
Piñar-Gutiérrez A; Dueñas Disotuar S; de Lara-Rodríguez I; Amuedo-Domínguez S; González-Cejudo C; Tejero-Delgado J; Mangas-Cruz MÁ
Endocrinol Diabetes Nutr (Engl Ed); 2024 Mar; 71(3):144-148. PubMed ID: 38555112
[TBL] [Abstract][Full Text] [Related]
14. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between Tobacco Use and Legal Document Gender-Marker Change, Hormone Use, and Gender-Affirming Surgery in a United States Sample of Trans-Feminine and Trans-Masculine Individuals: Implications for Cardiovascular Health.
Kidd JD; Dolezal C; Bockting WO
LGBT Health; 2018 Oct; 5(7):401-411. PubMed ID: 30334686
[TBL] [Abstract][Full Text] [Related]
16. Initial Clinical Needs Among Transgender and Non-binary Individuals in a Large, Urban Gender Health Program.
Gaither TW; Williams K; Mann C; Weimer A; Ng G; Litwin MS
J Gen Intern Med; 2022 Jan; 37(1):110-116. PubMed ID: 33904031
[TBL] [Abstract][Full Text] [Related]
17. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Gender-affirming Hormone Therapy on Anatomic Structures of the Brain Among Transgender Individuals.
O'Leary KB; Garcia-Altieri MA
J Psychiatr Pract; 2022 Jul; 28(4):328-334. PubMed ID: 35797690
[TBL] [Abstract][Full Text] [Related]
19. Clinical and sociodemographic characteristics as predictors for quality of life in transmasculine and transfeminine individuals receiving gender-affirming hormone therapy.
Lad SU; Sinopoli J; Khong B; Conroy B; Perzynski AT; Del Rincon JP
Soc Sci Med; 2024 Apr; 346():116734. PubMed ID: 38490912
[TBL] [Abstract][Full Text] [Related]
20. Psychosis in transgender and gender non-conforming individuals: A review of the literature and a call for more research.
Barr SM; Roberts D; Thakkar KN
Psychiatry Res; 2021 Dec; 306():114272. PubMed ID: 34808496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
